Literature DB >> 22148635

Virtual screening data fusion using both structure- and ligand-based methods.

Fredrik Svensson1, Anders Karlén, Christian Sköld.   

Abstract

Virtual screening is widely applied in drug discovery, and significant effort has been put into improving current methods. In this study, we have evaluated the performance of compound ranking in virtual screening using five different data fusion algorithms on a total of 16 data sets. The data were generated by docking, pharmacophore search, shape similarity, and electrostatic similarity, spanning both structure- and ligand-based methods. The algorithms used for data fusion were sum rank, rank vote, sum score, Pareto ranking, and parallel selection. None of the fusion methods require any prior knowledge or input other than the results from the single methods and, thus, are readily applicable. The results show that compound ranking using data fusion improves the performance and consistency of virtual screening compared to the single methods alone. The best performing data fusion algorithm was parallel selection, but both rank voting and Pareto ranking also have good performance.

Mesh:

Substances:

Year:  2011        PMID: 22148635     DOI: 10.1021/ci2004835

Source DB:  PubMed          Journal:  J Chem Inf Model        ISSN: 1549-9596            Impact factor:   4.956


  18 in total

1.  Ligand- and receptor-based docking with LiBELa.

Authors:  Heloisa dos Santos Muniz; Alessandro S Nascimento
Journal:  J Comput Aided Mol Des       Date:  2015-07-04       Impact factor: 3.686

2.  Receptor pharmacophore ensemble (REPHARMBLE): a probabilistic pharmacophore modeling approach using multiple protein-ligand complexes.

Authors:  Sivakumar Prasanth Kumar
Journal:  J Mol Model       Date:  2018-09-15       Impact factor: 1.810

3.  Voting-based consensus clustering for combining multiple clusterings of chemical structures.

Authors:  Faisal Saeed; Naomie Salim; Ammar Abdo
Journal:  J Cheminform       Date:  2012-12-17       Impact factor: 5.514

4.  Identification of novel antimalarial chemotypes via chemoinformatic compound selection methods for a high-throughput screening program against the novel malarial target, PfNDH2: increasing hit rate via virtual screening methods.

Authors:  Raman Sharma; Alexandre S Lawrenson; Nicholas E Fisher; Ashley J Warman; Alison E Shone; Alasdair Hill; Alison Mbekeani; Chandrakala Pidathala; Richard K Amewu; Suet Leung; Peter Gibbons; David W Hong; Paul Stocks; Gemma L Nixon; James Chadwick; Joanne Shearer; Ian Gowers; David Cronk; Serge P Parel; Paul M O'Neill; Stephen A Ward; Giancarlo A Biagini; Neil G Berry
Journal:  J Med Chem       Date:  2012-03-22       Impact factor: 7.446

5.  Enhanced ranking of PknB Inhibitors using data fusion methods.

Authors:  Abhik Seal; Perumal Yogeeswari; Dharmaranjan Sriram; David J Wild
Journal:  J Cheminform       Date:  2013-01-14       Impact factor: 5.514

6.  Prospective performance evaluation of selected common virtual screening tools. Case study: Cyclooxygenase (COX) 1 and 2.

Authors:  Teresa Kaserer; Veronika Temml; Zsofia Kutil; Tomas Vanek; Premysl Landa; Daniela Schuster
Journal:  Eur J Med Chem       Date:  2015-04-08       Impact factor: 6.514

7.  A linear combination of pharmacophore hypotheses as a new tool in search of new active compounds--an application for 5-HT1A receptor ligands.

Authors:  Dawid Warszycki; Stefan Mordalski; Kurt Kristiansen; Rafał Kafel; Ingebrigt Sylte; Zdzisław Chilmonczyk; Andrzej J Bojarski
Journal:  PLoS One       Date:  2013-12-18       Impact factor: 3.240

8.  Novel mycosin protease MycP₁ inhibitors identified by virtual screening and 4D fingerprints.

Authors:  Adel Hamza; Jonathan M Wagner; Timothy J Evans; Mykhaylo S Frasinyuk; Stefan Kwiatkowski; Chang-Guo Zhan; David S Watt; Konstantin V Korotkov
Journal:  J Chem Inf Model       Date:  2014-03-27       Impact factor: 4.956

9.  Function-specific virtual screening for GPCR ligands using a combined scoring method.

Authors:  Albert J Kooistra; Henry F Vischer; Daniel McNaught-Flores; Rob Leurs; Iwan J P de Esch; Chris de Graaf
Journal:  Sci Rep       Date:  2016-06-24       Impact factor: 4.379

Review 10.  Drug Design for CNS Diseases: Polypharmacological Profiling of Compounds Using Cheminformatic, 3D-QSAR and Virtual Screening Methodologies.

Authors:  Katarina Nikolic; Lazaros Mavridis; Teodora Djikic; Jelica Vucicevic; Danica Agbaba; Kemal Yelekci; John B O Mitchell
Journal:  Front Neurosci       Date:  2016-06-10       Impact factor: 4.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.